Published in Mol Vis on February 25, 2011
The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int (2015) 0.96
Bilateral corneal ulceration in ocular graft-versus-host disease. Clin Ophthalmol (2013) 0.81
Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation. Cornea (2015) 0.81
Grading criteria for chronic ocular graft-versus-host disease: comparing the NIH eye score, Japanese dry eye score, and DEWS 2007 score. Sci Rep (2014) 0.79
Recruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants. Invest Ophthalmol Vis Sci (2015) 0.77
Serum Vitamin A Levels May Affect the Severity of Ocular Graft-versus-Host Disease. Front Med (Lausanne) (2017) 0.75
A Case of Bilateral Corneal Perforation in a Patient with Severe Dry Eye. J Clin Diagn Res (2017) 0.75
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant (2005) 19.83
Hematopoietic stem-cell transplantation. N Engl J Med (2006) 10.45
Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol (2007) 10.17
Graft-versus-host disease. Lancet (2009) 8.78
Neurotrophic keratitis. Eye (Lond) (2003) 1.67
Ocular manifestations of graft-vs-host disease. Ophthalmology (1983) 1.50
Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology (1998) 1.49
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplant (2004) 1.37
Role of ocular matrix metalloproteinases in peripheral ulcerative keratitis. Br J Ophthalmol (1999) 1.28
Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD. Blood (2005) 1.27
Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea (2003) 1.25
Possible role of the vitamin E solubilizer in topical diclofenac on matrix metalloproteinase expression in corneal melting: an analysis of postoperative keratolysis. Ophthalmology (2002) 1.14
Update on ocular graft versus host disease. Curr Opin Ophthalmol (2006) 1.13
Corneal ulceration and perforation associated with Sjögren's syndrome. Arch Ophthalmol (1980) 1.12
Corneal melting associated with use of topical nonsteroidal anti-inflammatory drugs after ocular surgery. Arch Ophthalmol (2000) 1.10
Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci (2003) 1.05
The eye in bone marrow transplantation. II. Histopathology. Arch Ophthalmol (1983) 1.05
Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology (2009) 1.04
Corneal melt as the initial presentation of primary Sjögren's syndrome. J Rheumatol (2001) 0.97
Calcareous corneal degeneration: report of two cases. Cornea (1995) 0.91
Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol (2009) 0.91
Sterile corneal melt after descemet stripping endothelial keratoplasty in patients with previously undiagnosed Sjogren syndrome. Arch Ophthalmol (2009) 0.90
Abnormal keratocytes and stromal inflammation in chronic phase of severe ocular surface diseases with stem cell deficiency. Br J Ophthalmol (2008) 0.88
Recurrent corneal perforation and acute calcareous corneal degeneration in chronic graft-versus-host disease. J Formos Med Assoc (2006) 0.86
Matrix metalloproteinases in recurrent corneal melting associated with primary Sjörgen's syndrome. Mol Vis (2009) 0.85
A case of sterile corneal perforation after bone marrow transplantation. Eye (Lond) (2006) 0.83
Role of matrix metalloproteinases in recurrent corneal melting. Exp Eye Res (2010) 0.82
Progressive corneal vascularization caused by graft-versus-host disease. Cornea (2007) 0.80
Perforated corneal ulcer with subsequent endophthalmitis in a patient with graft-versus-host disease. Cornea (2007) 0.79
Corneal grafting and aggressive medication for corneal defects in graft-versus-host disease following bone marrow transplantation. Eye (Lond) (2006) 0.78
Nosocomial Klebsiella pneumoniae conjunctivitis resulting in infectious keratitis and bilateral corneal perforation. Cornea (1998) 0.78
Rheumatoid corneal melt. Rheumatology (Oxford) (2002) 0.76
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med (2009) 4.03
Modified double-K method for intraocular lens power calculation after excimer laser corneal refractive surgery. J Cataract Refract Surg (2013) 3.29
The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2011) 2.66
Drusen, choroidal neovascularization, and retinal pigment epithelium dysfunction in SOD1-deficient mice: a model of age-related macular degeneration. Proc Natl Acad Sci U S A (2006) 2.40
The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci (2011) 2.28
No forward shifting of posterior corneal surface in eyes undergoing LASIK. Ophthalmology (2007) 2.21
Topography-guided conductive keratoplasty: treatment for advanced keratoconus. Am J Ophthalmol (2010) 2.10
Development of mesenchymal stem cells partially originate from the neural crest. Biochem Biophys Res Commun (2009) 2.08
Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. Am J Ophthalmol (2004) 2.06
Impaired functional visual acuity of dry eye patients. Am J Ophthalmol (2002) 1.94
Human circulating CD14+ monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol (2003) 1.76
The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Am J Ophthalmol (2005) 1.74
The effect of periocular warming on accommodation. Ophthalmology (2005) 1.74
New grading system for the evaluation of chronic ocular manifestations in patients with Stevens-Johnson syndrome. Ophthalmology (2007) 1.71
Oxidative stress induced inflammation initiates functional decline of tear production. PLoS One (2012) 1.64
Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology (2008) 1.61
Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest Ophthalmol Vis Sci (2007) 1.59
Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol (2007) 1.54
Mathematical projection model of visual loss due to fuchs corneal dystrophy. Invest Ophthalmol Vis Sci (2011) 1.53
Cytokeratin 15 can be used to identify the limbal phenotype in normal and diseased ocular surfaces. Invest Ophthalmol Vis Sci (2006) 1.53
Noninvasive interference tear meniscometry in dry eye patients with Sjögren syndrome. Am J Ophthalmol (2007) 1.51
How does amniotic membrane work? Ocul Surf (2004) 1.51
Isolation of multipotent neural crest-derived stem cells from the adult mouse cornea. Stem Cells (2006) 1.49
Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology (2004) 1.48
Biological effects of blocking blue and other visible light on the mouse retina. Clin Experiment Ophthalmol (2013) 1.46
Subjective visual sensation during vitrectomy under retrobulbar anesthesia. Am J Ophthalmol (2006) 1.46
The comparison of solitary topical micafungin or fluconazole application in the treatment of Candida fungal keratitis. Br J Ophthalmol (2010) 1.43
Prevalence and risk factors of dry eye disease in Japan: Koumi study. Ophthalmology (2011) 1.43
The features of dry eye disease in a Japanese elderly population. Optom Vis Sci (2006) 1.41
Ocular integrity after anterior ciliary sclerotomy and scleral ablation by the Er:YAG laser. J Refract Surg (2005) 1.41
Accessory cell populations in the cornea. Ocul Surf (2006) 1.41
Tear function and ocular surface findings in premature and term babies. Ophthalmology (2004) 1.41
Effect of age on changes in anterior chamber depth and volume after laser in situ keratomileusis. J Cataract Refract Surg (2009) 1.41
Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity. Mod Rheumatol (2004) 1.40
Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology (2005) 1.40
Microkeratome-assisted phacoemulsification. J Cataract Refract Surg (2005) 1.38
Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study. Am J Ophthalmol (2013) 1.37
Laboratory findings in tear fluid analysis. Clin Chim Acta (2006) 1.36
Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology (2002) 1.35
Beta-catenin activation and epithelial-mesenchymal transition in the pathogenesis of pterygium. Invest Ophthalmol Vis Sci (2007) 1.30
Randomized clinical trial of deep lamellar keratoplasty vs penetrating keratoplasty. Am J Ophthalmol (2002) 1.30
A randomised, double-masked comparison study of diquafosol versus sodium hyaluronate ophthalmic solutions in dry eye patients. Br J Ophthalmol (2012) 1.29
Prevention of ocular inflammation in endotoxin-induced uveitis with resveratrol by inhibiting oxidative damage and nuclear factor-kappaB activation. Invest Ophthalmol Vis Sci (2009) 1.25
Deep anterior lamellar keratoplasty. Curr Opin Ophthalmol (2006) 1.25
High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci (2005) 1.24
Novel enzymatic isolation of an entire viable human limbal epithelial sheet. Invest Ophthalmol Vis Sci (2003) 1.24
Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation. Invest Ophthalmol Vis Sci (2006) 1.24
Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci (2007) 1.24
(Pro)renin receptor-mediated signal transduction and tissue renin-angiotensin system contribute to diabetes-induced retinal inflammation. Diabetes (2009) 1.24
Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol (2007) 1.23
The application of a new continuous functional visual acuity measurement system in dry eye syndromes. Am J Ophthalmol (2005) 1.21
Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest Ophthalmol Vis Sci (2008) 1.21
Serum-free spheroid culture of mouse corneal keratocytes. Invest Ophthalmol Vis Sci (2005) 1.20
Intrinsic signal imaging in macaque retina reveals different types of flash-induced light reflectance changes of different origins. Invest Ophthalmol Vis Sci (2007) 1.20
Angiotensin II type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes (2008) 1.19
Suppression of ocular inflammation in endotoxin-induced uveitis by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci (2005) 1.18
Turning point in apoptosis/necrosis induced by hydrogen peroxide. Free Radic Res (2006) 1.18
The application of in vivo laser confocal microscopy to the diagnosis and evaluation of meibomian gland dysfunction. Mol Vis (2008) 1.18
Tearful relations: oxidative stress, inflammation and eye diseases. Arq Bras Oftalmol (2009) 1.18
Dietary restriction: standing up for sirtuins. Science (2010) 1.17
Eicosapentaenoic acid is anti-inflammatory in preventing choroidal neovascularization in mice. Invest Ophthalmol Vis Sci (2007) 1.17
Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol (2007) 1.16
CD-34 expression by cultured human keratocytes is downregulated during myofibroblast differentiation induced by TGF-beta1. Invest Ophthalmol Vis Sci (2004) 1.16
Transient receptor potential vanilloid 1 activation induces inflammatory cytokine release in corneal epithelium through MAPK signaling. J Cell Physiol (2007) 1.16
Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci (2003) 1.14
A new mouse model of dry eye disease: oxidative stress affects functional decline in the lacrimal gland. Cornea (2012) 1.14
Suppression of ocular inflammation in endotoxin-induced uveitis by inhibiting nonproteolytic activation of prorenin. Invest Ophthalmol Vis Sci (2006) 1.14
Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol (2007) 1.13
Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro. Exp Eye Res (2005) 1.13
Preparation and application of monoclonal antibodies against oxidized DJ-1. Significant elevation of oxidized DJ-1 in erythrocytes of early-stage Parkinson disease patients. Neurosci Lett (2009) 1.13
Functional corneal endothelium derived from corneal stroma stem cells of neural crest origin by retinoic acid and Wnt/β-catenin signaling. Stem Cells Dev (2012) 1.12
Autologous serum eye drops for the treatment of dry eye diseases. Cornea (2008) 1.12